Cibus Provides Webcast of BofA Securities AgTech Virtual Conference Fireside Chat

Rhea-AI Summary

Cibus (NASDAQ: CBUS), an agricultural biotechnology company specializing in proprietary gene editing technologies for seed trait development, has made available a replay of its participation in the BofA Securities 2025 AgTech Virtual Conference. During the fireside chat, Co-Founder, President and Interim CEO Peter Beetham discussed with BofA analyst Stephen Byrne three key areas: the company's unique gene editing platform, progress in their productivity trait pipeline toward commercial goals, and the impact of recent regulatory changes supporting agricultural innovation globally. The webcast recording can be accessed through Cibus's investor relations website.

SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Peter Beetham, Co-Founder, President and Interim Chief Executive Officer, participated in the BofA Securities 2025 AgTech Virtual Conference this week.

During the fireside chat, hosted by BofA research analyst Stephen Byrne, management discussed the Company's differentiated gene editing platform, the progression of its productivity trait pipeline towards commercial milestones and how the advancements in recent regulatory developments are supporting agricultural innovation in global markets.

The webcast is now available for replay in the events section of the Company's investor relations website at https://investor.cibus.com/events.

About Cibus

Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop and license traits to seed companies in exchange for royalties on seed sales. Cibus' long-term focus is productivity traits for farmers for the major global row crops with large acreage such as canola, corn, rice, soybean, and wheat. Cibus is a technology leader in high-throughput gene editing technology that is expected to enable it to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus has developed a current pipeline of five productivity traits including important traits for weed management in Rice, Pod Shatter Reduction, and Sclerotinia (disease) resistance, which are its near-term focus.

CIBUS CONTACTS:

INVESTOR RELATIONS
Karen Troeber
ktroeber@cibus.com
858-450-2636

Jeff Sonnek – ICR
jeff.sonnek@icrinc.com

MEDIA RELATIONS
Colin Sanford
colin@bioscribe.com
203-918-4347

FAQ

What topics did Cibus (CBUS) discuss at the BofA Securities 2025 AgTech Conference?

Cibus discussed three main topics: their gene editing platform technology, progress in productivity trait pipeline commercialization, and the impact of recent regulatory developments on agricultural innovation.

Who represented Cibus at the BofA Securities 2025 AgTech Conference?

Peter Beetham, who serves as Co-Founder, President and Interim Chief Executive Officer of Cibus, represented the company at the conference.

Where can investors access the replay of Cibus's BofA Securities conference presentation?

The webcast replay is available in the events section of Cibus's investor relations website at https://investor.cibus.com/events.

What is Cibus's (CBUS) main business focus?

Cibus is an agricultural biotechnology company that develops plant traits in seeds using proprietary gene editing technologies.